Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.
Immunocore Holdings PLC Sponsored ADR (IMCR) had Non-Operating Income/Expense of $2.48M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$115.93M |
|
$-0.81M |
|
$1.09M |
|
$114.84M |
|
$118.92M |
|
$-3.00M |
|
|
Non-Operating Income/Expense |
$2.48M |
$-0.51M |
|
$-0.51M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-3.00M |
|
$-1.97M |
|
50.97M |
|
50.97M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$1.05B |
|
$12.86M |
|
$68.38M |
|
$1.12B |
|
$235.20M |
|
$394.21M |
|
$464.43M |
|
$699.62M |
|
$419.80M |
|
$419.80M |
|
$419.80M |
|
51.48M |
|
| Cash Flow Statement Financials | |
$2.15M |
|
$3.43M |
|
$17.14M |
|
$467.71M |
|
$484.92M |
|
$17.21M |
|
$15.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.47 |
|
-- |
|
-- |
|
0.48 |
|
0.94 |
|
99.06% |
|
-2.58% |
|
-2.58% |
|
-- |
|
-0.44% |
|
-0.70% |
|
$-0.41M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.14 |
|
1.22 |
|
74.03 |
|
-0.19% |
|
-0.19% |
|
-0.07% |
|
-0.10% |
|
$8.15 |
|
$-0.01 |
|
$0.04 |
|